These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15027049

  • 1. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
    Whelchel DD, Brehmer TM, Brooks PM, Darragh N, Coffield JA.
    Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
    [Abstract] [Full Text] [Related]

  • 2. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
    Fernández-Salas E, Ho H, Garay P, Steward LE, Aoki KR.
    Mov Disord; 2004 Mar; 19 Suppl 8():S23-34. PubMed ID: 15027051
    [Abstract] [Full Text] [Related]

  • 3. Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.
    Gerachshenko T, Blackmer T, Yoon EJ, Bartleson C, Hamm HE, Alford S.
    Nat Neurosci; 2005 May; 8(5):597-605. PubMed ID: 15834421
    [Abstract] [Full Text] [Related]

  • 4. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
    Raciborska DA, Trimble WS, Charlton MP.
    Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
    [Abstract] [Full Text] [Related]

  • 5. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
    Kalandakanond S, Coffield JA.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932
    [Abstract] [Full Text] [Related]

  • 6. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
    Foran P, Lawrence GW, Shone CC, Foster KA, Dolly JO.
    Biochemistry; 1996 Feb 27; 35(8):2630-6. PubMed ID: 8611567
    [Abstract] [Full Text] [Related]

  • 7. Activity-dependent changes in partial VAMP complexes during neurotransmitter release.
    Hua SY, Charlton MP.
    Nat Neurosci; 1999 Dec 27; 2(12):1078-83. PubMed ID: 10570484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin.
    Zhou JY, Wang ZF, Ren XM, Tang MZ, Shi YL.
    FEBS Lett; 2003 Dec 04; 555(2):375-9. PubMed ID: 14644446
    [Abstract] [Full Text] [Related]

  • 16. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B, Lonchamp E, Jover E, Popoff MR, Molgó J.
    Ann Dermatol Venereol; 2009 May 04; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New insights into clostridial neurotoxin-SNARE interactions.
    Breidenbach MA, Brunger AT.
    Trends Mol Med; 2005 Aug 04; 11(8):377-81. PubMed ID: 16006188
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.